Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant for the study of repetitive DNA and RNA sequences and the mechanisms by which they cause cell dysfunction and diseases.
The university has announced a realignment within the Office of the Executive Vice President and Chief Financial Officer designed to improve long-term financial oversight and cross-campus coordination between Ithaca and Weill Cornell Medicine in New York City.
Structural insights into a potent antimalarial drug candidate’s interaction with a malaria parasite have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.
Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by researchers at Weill Cornell Medicine.
A multidisciplinary task force of Cornell faculty and staff has issued a report offering perspectives and practical guidelines for the use of generative artificial intelligence in the practice and dissemination of Cornell’s academic research.
A new study found that patients with non-small cell lung cancer treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy alone.
In her annual Address to Staff on Jan. 11 – Ezra Cornell’s 216th birthday – President Martha E. Pollack highlighted achievements that are helping to sustain and re-imagine the university’s founding “… any person … any study” vision.
